SEVEN EIGHT CAPITAL, LP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$527,0000.0%33,8000.0%0.12%
+0.8%
Q4 2020$527,000
+113.4%
33,800
+29.2%
0.12%
+126.4%
Q3 2020$247,000
-44.9%
26,155
-44.4%
0.05%
+120.8%
Q1 2019$448,000
-62.7%
47,000
-25.7%
0.02%
-75.8%
Q1 2018$1,202,000
+230.2%
63,289
+185.1%
0.10%
+167.6%
Q4 2017$364,00022,2000.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders